Introduction {#Sec1}
============

Many environmental factors as well as endogenous disturbances in blood oxygenation and circulation are often associated with limitations in the oxygen delivery to tissues and cells. Severe deprivation in adequate oxygen supply may cause marked tissue damage and finally lead to hypoxic cell death (Busl and Greer [@CR5]; Goni-de-Cerio et al. [@CR21]; Hossain [@CR24]; Minko et al. [@CR39]; Minko et al. [@CR40]; Soleymanlou et al. [@CR54]; Vacotto et al. [@CR57]). Moreover, reoxygenation---a restoration of oxygen supply to the formerly hypoxic tissues as a result of the treatment, compensatory reactions of an organism, or ending of exogenous hypoxic conditions may lead even to more pronounced tissue damage (Dhar-Mascareno et al. [@CR14]; Freiberg et al. [@CR16]; Hung and Burton [@CR26]; Kim et al. [@CR28]; Ricci et al. [@CR51]; Yajima et al. [@CR62]). Despite substantial differences in the physiological conditions during hypoxia and reoxygenation, the main mechanisms of tissue damage under both settings are quite similar. The major mechanisms include disturbances in cellular metabolism, mitochondrial dysfunctions, disturbances in acid--base homeostasis, oxidative stress damage by active oxygen and nitrogen species, and apoptotic and necrotic cell death (Blokhina and Fagerstedt [@CR3]; Boning et al. [@CR4]; Cho et al. [@CR9]; Gonchar and Mankovskaya [@CR20]; Kim et al. [@CR29]; Kim and Park [@CR30]; Kothari et al. [@CR32]; Minko et al. [@CR39]; Minko et al. [@CR40]; Murray et al. [@CR41]; Portugal-Cohen and Kohen [@CR49]; Surova et al. [@CR56]; Vacotto et al. [@CR57]; Yajima et al. [@CR62]). Consequently, the suppression of the above-mentioned mechanisms of hypoxic cellular damage can potentially be used in effective therapy of many diseases associated with hypoxia and/or reoxygenation and to increase the resistance to damaging environmental factors. Several approaches have been recently proposed including preliminary adaptation to hypoxia, stress, and other environmental factors (Boning et al. [@CR4]; Corbucci et al. [@CR10]; Gonchar and Mankovskaya [@CR20]; Meerson et al. [@CR35]; Millet et al. [@CR36]; Ostadal and Kolar [@CR44]; Zhao et al. [@CR63]) as well as many pharmacological methods (Betigeri et al. [@CR2]; Carlsson et al. [@CR6]; Cho et al. [@CR8]; Danielyan et al. [@CR12]; Lecour et al. [@CR33]; Minciu Macrea et al. [@CR37]; Minko et al. [@CR39]; Minko et al. [@CR40]; Myllyharju [@CR42]; Nagel et al. [@CR43]; Surova et al. [@CR56]; Wenger et al. [@CR61]; Zhu et al. [@CR65]).

Hypoxia inducible factor one alpha (HIF1A) protein is a key initiator of cell death signal under hypoxic conditions (Hellwig-Burgel et al. [@CR23]). We investigated the role of this protein as a possible target for the remediation of hypoxic cellular damage and found that HIF1A plays a bimodal role during hypoxia (Wang and Minko [@CR58]; Wang et al. [@CR59]; Wang et al. [@CR60]). On the one hand, activation of HIF1A during hypoxia initiates cell death signal inducing apoptosis (programmed cell death or cellular suicide) and necrosis (pathological cell death). On the other hand, overexpression of HIF1A boosts the power of anti-hypoxic systems that increase cellular resistance to hypoxia.

Recently, we identified Jun N-terminal kinase 1 (JNK1), another major player in the activation of apoptosis signaling pathways and hypoxic damage from the mitogen-activated protein kinas (MAPK) family of proteins, as a prospective target for pharmacological prevention of cellular damage during severe hypoxia (Betigeri et al. [@CR2]). It has been shown that JNK1 as a stress-activated protein kinase can be induced by inflammatory cytokines, bacterial endotoxin, osmotic shock, UV radiation, and hypoxia (Bennett et al. [@CR1]; Chihab et al. [@CR7]; Zhou et al. [@CR64]). Analysis of literature data (Bennett et al. [@CR1]; Derijard et al. [@CR13]; Karin [@CR27]) showed that cellular hypoxic damage can be induced by the pathway presented in Fig. [1](#Fig1){ref-type="fig"}. Induction of JNK by hypoxia mediates phosphorylation of activating transcriptional factor-2 (ATF2) and c-Jun bound to the *c-Jun* promoter and stimulates their transcriptional activities leading to *c-Jun* activation. The newly synthesized c-Jun protein combines with c-Fos protein to form stable transcriptional factor activator protein-1 (AP1) heterodimers. The formation of AP1 is a key step following the induction of central cell death signal leading to the activation of caspase-dependent apoptosis signal pathways and finally causing cell death. It was found that c-Jun N-terminal kinase 1 (JNK1, SAPK1 and MAPK8) plays a central role in the development of cellular damage under hypoxia, hypoxia/reoxygenation, and ischemia/reperfusion conditions (Crenesse et al. [@CR11]; Garay et al. [@CR17]; Hreniuk et al. [@CR25]). The in vitro data previously obtained in our laboratory showed that the suppression of JNK1 by antisense oligonucleotides (ASO) or small interfering RNA (siRNA) targeted to JNK1 mRNA substantially limited cellular mortality after severe hypoxia (Betigeri et al. [@CR2]). The present study is a logical continuation of our previous work and is aimed at in vivo testing of this approach. Fig. 1Schema of apoptosis induction by hypoxia. Activation of Jun N-terminal kinase (*JNK*) by hypoxia mediates phosphorylation of activating transcriptional factor-2 (*ATF2*) and c-Jun and stimulates their transcriptional activities. The newly synthesized c-Jun protein combines with c-Fos protein to form stable transcriptional factor activator protein-1 (*AP1*) heterodimers. The formation of AP1 activates caspase-dependent apoptosis signal and finally induces cell death

Material and methods {#Sec2}
====================

Liposomal compositions of siRNA and ASO {#Sec3}
---------------------------------------

Negatively charged siRNA was delivered by cationic liposomes (N-\[1-(2,3-Dioleoyloxy) propyl\]-*N*,*N*,*N*-trimethylammonium methylsulfate, DOTAP, Avanti Polar Lipids, Alabaster, AL). ASO targeted to JNK1 mRNA (5′-CTC TCT GTA GGC CCG CTT GG-3′) (Garay et al. [@CR17]) and ASO labeled with fluorescein isothiocyanate (FITC) were synthesized by Oligos Etc. (Wilsonville, OR). The DNA backbone of all bases in oligonucleotides was P-ethoxy modified in order to eliminate electrical charge and increase incorporation efficacy into "neutral" PEGylated liposomes. Liposomes were prepared as described previously (Garbuzenko et al. [@CR18]; Garbuzenko et al. [@CR19]; Pakunlu et al. [@CR46]). Briefly, to prepare PEGylated liposomes, egg phosphotidyl choline, cholesterol, and DSPE-PEG (1,2-distearoyl-sn-glycero-3-phosphoetanolamine-*N*-aminopolyethylene glycol-M~w~ ∼ 2,000 ammonium salt) were dissolved in 4.0 ml of chloroform at 1.85:1:0.15 molar ratio, respectively (all compounds were obtained from Avanti Polar Lipids, Alabaster, AL). The clear lipid solution was evaporated at 25°C under reduced pressure. A thin layer was formed and rehydrated using 2.0 ml of 0.3 M sodium citrate buffer (pH = 4.0). ASO was loaded into liposomes by dissolving in rehydration buffer at concentration 0.5 mM. The lipid mixture was sonicated continuously for 3.0 h to obtain stealth liposomes. Liposomes were extruded gradually through 100 and 200 nm polycarbonate membranes at room temperature using an extruder device from Northern Lipids, Inc. (Vancuver, BC, Canada). Liposomes were separated from non-encapsulated ASO by dialysis against 100 volumes of 0.9% NaCl. The encapsulation efficacy of ASO was ∼50--60%, respectively. The final phospholipids concentration was 10 mg/ml. Mean diameter of "neutral" liposomes was 100--140 nm. siRNA targeted to exon 1 JNK1 mRNA (sense sequence---3′-GGA GCU CAA GGA AUA GUA UTT-5′) was selected based on the results of our previous studies (Betigeri et al. [@CR2]) and synthesized according to our design by Ambion (Austin, TX). A siGLO Green 6-FAM transfection indicator was purchased from Dharmacon, Inc. (Chicago, IL). siRNA possess negative charges requiring positively charged (cationic) liposomes to form stable complexes. Cationic liposomes were prepared from positively charged DOTAP at concentration 5 mg/mL using thin layer procedure as previously described (Betigeri et al. [@CR2]; Garbuzenko et al. [@CR18]), followed by extrusion through 100 nm polycarbonate membrane. The siRNA was dissolved in RNase free water at a concentration of 400 μM. To this solution, appropriate volume of DOTAP (5 mg/mL) was added, mixed by pipette and incubated for 30 min at room temperature. The molar ratio of siRNA/DOTAP was ∼1:100. Resulting siRNA-cationic liposome complex was used in the studies. siGLO Green was dissolved in RNAse free solution to the final concentration of 200 μM. DOTAP liposomes were mixed with siGLO in the ration 6:1 *v*/*v* and incubated at room temperature for 15 min before use. Mean DOTAP/siGLO complex size was around 500 nm. Aliquots of each liposomal formulation were labeled with near infrared fluorescent dye Cy5.5 Mono NHS Ester (GE Healthcare, Amersham, UK). A fluorescent dye was dissolved together with lipids in chloroform. Approximate excitation/emission maxima of all fluorescent substances used in the study are: 675/694 nm (Cy5.5); 520/594 nm (siGLO Green, siRNA labeled with 6-FAM dye); 494/518 nm (FITC).

Liposome size and zeta potential {#Sec4}
--------------------------------

Particle size was measured by dynamic light scattering using 90 Plus Particle Sizer Analyzer (Brookhaven Instruments Corp., New York, NY). Aliquot of 40 μL of each sample was diluted in 2 mL of saline. Zeta potential was measured on PALS Zeta Potential Analyzer (Brookhaven Instruments Corp, New York, NY). Samples were taken as is and their volume was 1.5 mL. All measurements were carried out at room temperature. Each parameter was measured in triplicate, and average values were calculated.

Cell line {#Sec5}
---------

The human embryonic kidney 293 cells were obtained from American Type of Tissue Culture (Manassas, VA). Cells were cultured in Dulbecco\'s modified Eagle\'s medium (GIBCO Inc., Cincinnati, OH) supplemented with 10% fetal bovine serum (Fisher Chemicals, Fairlawn, NJ). All experiments were performed on cells in the exponential growth phase.

Cellular uptake and localization of liposomes, ASO and siRNA {#Sec6}
------------------------------------------------------------

Cellular internalization of liposomes, ASO and siRNA were monitored by fluorescence microscopy. Four series of the experiments were carried out: (1) "neutral" liposomes labeled with Cy5.5 (red fluorescence); (2) cationic liposomes labeled with Cy5.5 (red fluorescence); (3) ASO labeled with FITC (green fluorescence) delivered by "neutral" liposomes; and (4) siRNA labeled with 6-FAM (siGLO Green, green fluorescence) delivered by cationic liposomes. Cells were separately incubated for 24 h at 37°C with each liposomal formulation.

Animal model of hypoxia exposure {#Sec7}
--------------------------------

Experiments were performed on healthy 6--8 weeks old SKH1-hr hairless mice (25--35 g) obtained from Charles River Laboratories (Wilmington, MA). Veterinary care followed the guidelines described in the guide for the care and use of laboratory animals as well as the requirements established by the animal protocol approved by the Rutgers Institutional Animal Care and Use Committee. All mice were contained in micro-isolated cages under pathogen free conditions at room temperature with humidity of 40 ± 15% and light/dark cycle on 12 h per day in the animal maintenance facility. Normobaric hypoxia was created in a 300 × 350 × 600 mm Plexiglas chamber specifically designed for this project by Billups-Rothenberg, Inc. (Del Mar, CA). Hypoxia was induced by subjecting the chamber to a constant flow (15--20 l/min) of hypoxic gas mixture containing 6% oxygen and 94% nitrogen. The oxygen concentration in the chamber was continuously monitored using an oxygen analyzer (Vascular Technology, Inc., Nashua, NH). A heating pad was placed inside the Plexiglass chamber to maintain the body temperature of the mice. All animals were placed in the chamber for 2 h. Prior to exposure, mice were pretreated with 100 μL of different formulations by intravenous injection. Mice were randomized into six experimental groups: (1) normoxia (room air, 21% O~2~) following injection of saline; (2) hypoxia (6% O~2~) following injection of saline; (3) hypoxia (6% O~2~) following injection of neutral liposomes; (4) hypoxia (6% O~2~) following injection of cationic liposomes; (5) hypoxia (6% O~2~) following injection of neutral liposomes with ASO targeted to JNK1 mRNA; (6) hypoxia (6% O~2~) following injection of cationic liposomes with siRNA targeted to JNK1 mRNA. The doses of ASO and siRNA were 13 nmoles per mouse (80 and 173 μg ASO and siRNA, respectively). After the treatment, all mice were anesthetized with isoflurane and euthanized. The organs (lungs, heart, liver, kidney, spleen, and brain) were excised and used for the evaluation of body distribution of liposomes and their payloads (siRNA and ASO), study of lactic acid, apoptosis, gene and protein expression and histopathological analysis.

Content of liposomes in different organs {#Sec8}
----------------------------------------

The distribution of fluorescent-labeled "neutral" and cationic liposomes and their payloads (ASO and siRNA) was examined in mouse lungs, heart, liver, spleen, and kidneys. The organs were excised, rinsed in saline, and fluorescence was registered by IVIS imaging system (Xenogen Corporation, Alameda, CA). Visible light and fluorescence images were taken and overlaid. The intensity of fluorescence was represented on composite light/fluorescent images by different colors with blue color reflecting the lowest fluorescence intensity and red color---the highest intensity. Images of each organ were then scanned and total fluorescence intensity was calculated by a special computer program originally developed for our laboratory by Dr. V. P. Pozharov as previously described (Garbuzenko et al. [@CR18]; Garbuzenko et al. [@CR19]). Preliminary experiments showed a strong linear correlation between the total amount of labeled substance accumulated in the organ and calculated total fluorescence intensity. The fluorescence was expressed in arbitrary units with 1 unit represented approximately 2 × 10^10^ photons/s/sr/cm^2^. The method allows a quantitative comparison of the concentration of the same fluorescent dye between different series of the experiments. The mass of all organs was measured. No statistical differences were found in the mass of the same organ between all experimental groups of animals. The fluorescence intensity was normalized for organ weight.

Lactic acid and protein concentration {#Sec9}
-------------------------------------

Approximately 30--40 mg of tissues was weighed, lysed in Ripa buffer (Santa Cruz Biotechnologies, Inc., Santa Cruz, CA) and homogenized using Ultra Turrax T-25 basic homogenizer (IKA Works, Wilmington, NC). To confirm the existence of cellular hypoxia, the concentration of lactic acid in tissue homogenates was measured by an enzymatic assay kit (Sigma, St. Louis, MO) and was expressed per g of protein determined using the BCA protein assay kit (Pierce, Rockford, IL).

Gene expression {#Sec10}
---------------

Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was used for the analysis of genes encoding JNK1, caspase 9, and β-actin as previously described (Betigeri et al. [@CR2]; Dharap et al. [@CR15]; Minko et al. [@CR38]; Pakunlu et al. [@CR45]; Pakunlu et al. [@CR47]; Wang et al. [@CR59]) RNA was isolated using an RNeasy kit (Qiagen, Valencia, CA). The following pair of primers were used: JNK1, 5′-TTGGAACACCATGTCCTGAA-3′ (sense) and 5′-ATG TAC GGG TGT TGG AGA GC-3′ (antisense); caspase 9, 5′-TGA CTG CCA AGA AAA TGG TG-3′ (sense) and 5′-CAG CTG GTC CCA TTG AAG AT-3′ (antisense); and β-actin, 5′-GAC AAC GGC TCC GGC ATG TGC A 3′ (sense) and 5′-TGA GGA TGC CTC TCT TGC TCT G-3′ (antisense). Gene expression was calculated as the ratio of analyzed RT-PCR product to the internal standard (*β-actin*).

Protein expression {#Sec11}
------------------

To confirm RT-PCR data the expression of JNK1 protein and caspase 9 were measured by two methods: Western immunoblotting analysis and immunohistochemistry. The identification of the above proteins was conducted by Western immunoblotting analysis and processed using scanning densitometry to quantify the expressed proteins. To this end, approximately 30--40 mg of the tissue from each organ was weighed, lysed in Ripa buffer (Santa Cruz Biotechnologies, Inc., Santa Cruz, CA), and homogenized using Ultra Turrax T-25 basic homogenizer (IKA Works, Wilmington, NC). Following incubation on ice for 45 min, the tissues were centrifuged at 10,000×*g* for 10 min. Protein content in the supernatant was determined using the BCA Protein Assay Kit (Pierce, Rockford, IL) and 40 μg of protein was run on a 15% sodium dodecyl sulphate (SDS) polyacrylamide gel immersed in Tris/Glycine/SDS buffer (BioRad, Hercules, CA) for 90 min at 70 V. Proteins were transferred to an Immobilon-P nitrocellulose membrane (Millipore, Bedford, MA) in a Tris/Glycine buffer (BioRad, Hercules, CA) for 90 min at 100 V. The membrane was blocked in non-fat milk for 2 h at room temperature on a rotating shaker to prevent non-specific binding, washed and incubated overnight with anti-JNK1 mouse primary antibody (1:2,000 dilution, Cell Signaling Technology, Inc., Beverly, MA), anti-caspase 9 rabbit primary antibody (1:2,000 dilution, Stress Gen Biotechnologies, Victoria State, BC Canada) and anti-b-actin mice primary antibody (1:2,000 dilution, Oncogene Research, San Diego, CA) at 4°C. Following further washing, the membrane was immersed in goat anti-rabbit and goat anti-mouse IgG biotinylated antibodies (1:3,000 and 1:1,000 dilution, respectively, BioRad, Hercules, CA) at room temperature for 1.5 h on a rotating shaker. Bands were visualized using an alkaline phosphatase color development reagent (BioRad, Hercules, CA). The bands were digitally photographed and scanned using Gel Documentation System 920 (NucleoTech, San Mateo, CA). β-actin was used as an internal standard to normalize protein expression. Protein expression was calculated as the ratio of mean band density of the analyzed protein to that of the internal standard (β-actin). The identification of the JNK1 protein was also made by immunohistochemical staining of paraffin embedded tissue sections. After deparaffinization and rehydration, the slides were stained using Vector® M.O.M. Immunodetection Kit (Vector Laboratories, Inc., Burlingame, CA). Mouse monoclonal antibody to JNK1 (Cell Signaling Technology, Inc., Beverly, MA, 1:40 dilution) was used as the primary antibody for detection. Biotinylated anti-mouse IgG Reagent (1:250 dilution, Vector Laboratories, Inc., Burlingame, CA) and HSP-Streptavidine Detection System (1:500 dilution, Vector Laboratories, Inc., Burlingame, CA) in combination with DAB substrate kit for peroxidase were used for visualization. After staining, the slides were analyzed by light microscopy and photographed.

Apoptosis {#Sec12}
---------

Apoptosis was analyzed by measuring the enrichment of histone-associated DNA fragments (mono- and oligo-nucleosomes) in the cell cytoplasm using anti-histone and anti-DNA antibodies by a cell death detection ELISA Plus kit (Roche, Nutley, NJ) as previously described (Dharap et al. [@CR15]; Pakunlu et al. [@CR47]; Wang et al. [@CR59]).

Histopathological examination {#Sec13}
-----------------------------

After sacrificing animals, the organs were excised and immediately fixed in 10% phosphate-buffered formalin. Samples were subsequently dehydrated and embedded in Paraplast®. Five-micrometer slides were cut and stained with hematoxylin-eosin and analyzed.

Statistical analysis {#Sec14}
--------------------

Data obtained were analyzed using descriptive statistics, single-factor analysis of variance, and presented as mean values ± the standard deviation (SD) from four to eight independent measurements in separate experiments. The comparison among groups was performed by the independent sample Student's *t* tests. The difference between variants is considered significant if *P* \< 0.05.

Results {#Sec15}
=======

Particle size and zeta potential {#Sec16}
--------------------------------

Our data showed that the size of all formulations of "neutral" liposomes (empty and with ASO) was 100--140 nm. The average size of empty cationic liposomes and DOTAP/siRNA complexes was 120 and 500 nm, respectively. "Neutral" liposomes had a slight negative charge (−10 ± 2 mV). DOTAP liposomes had a positive charge (+25 ± 4 mV). The formation of DOTAP/siRNA complexes decreased the surface charge to +4 ± 2 mV likely due to the electrostatic interactions between positively charged lipid and negatively charged siRNA.

Development of tissue hypoxia {#Sec17}
-----------------------------

The accumulation of lactic acid in tissues was used as a hallmark of the development of severe tissue hypoxia in different organs of mice during exogenous hypoxia. Data obtained show that the exposure of mice to 6% O~2~ in the inspired gas mixture led to a significant increase of the absolute concentration of lactic acid in all studied organs within 2 h (Fig. [2a](#Fig2){ref-type="fig"}). The most dramatic relative increase in the lactic acid concentration in tissues was registered in the brain, heart, spleen, and lungs (Fig. [2b](#Fig2){ref-type="fig"}). These data clearly show that the experimental conditions used led to the development of a severe tissue hypoxia in many organs of mice exposed to the hypoxic gas mixture. Fig. 2Accumulation of lactic acid in different organs under hypoxia. **a** Absolute values. **b** Lactic acid growth under hypoxia relative to normoxia values. Hypoxia was induced in mice by the inhalation of gas mixture containing 6% O~2~ for 2 h. Means ± SD are shown. \**P* \< 0.05 when compared with normoxia

Delivery of ASO and siRNA {#Sec18}
-------------------------

Our previous findings showed that naked ASO and siRNA poorly penetrate cellular plasma membrane and therefore require special delivery systems for efficient intracellular uptake (Patil et al. [@CR48]; Wang et al. [@CR60]). Consequently, neutral and cationic phospholipid liposomes were used to deliver neutral P-ethoxy ASO and negatively charged siRNA, respectively. In vitro data obtained in the present study demonstrate that liposomes provide for an effective intracellular delivery of both ASO and siRNA (Fig. [3](#Fig3){ref-type="fig"}). Delivered by liposomes ASO were distributed homogenously in the cytoplasm and nucleus of exposed cells, while siRNA was accumulated predominately in the cytoplasm. These data allowed us to use both types of liposomes for systemic delivery of ASO and siRNA in vivo. The analysis of body distribution of liposomes and delivered payload showed that the content of liposomes, ASO and siRNA per gram of wet tissue was highest in the lungs. In contrast, only trace amounts of liposomes and payload were found in the brain. A substantial amount of ASO or siRNA was found in the heart (Fig. [4](#Fig4){ref-type="fig"}). Based on the organ content of active components as well as on the degree of tissue hypoxia, we selected the lungs (the highest ASO or siRNA accumulation and moderate hypoxia), heart (moderate hypoxia and moderate ASO or siRNA accumulation) and brain (the highest hypoxia and the lowest ASO or siRNA accumulation) for further detailed study. Fig. 3Intracellular localization of neutral and cationic liposomes, antisense oligonucleotides (*ASO*) and siRNA delivered by neutral and cationic liposomes, respectively. Representative fluorescence images of cells incubated 120 min with substances indicated. Neutral and cationic liposomes were labeled by Cy5.5 (*red*), ASO were labeled by FITC (*green*), siRNA were labeled by FAM (siGLO Green)Fig. 4Relative tissue content of empty neutral and cationic liposomes, antisense oligonucleotides (*ASO*) and small interfering RNA (*siRNA*) in different organs. Neutral P-ethoxy ASO and negatively charged siRNA were delivered by neutral and cationic liposomes, respectively. Liposomes, ASO and siRNA were labeled with fluorescent dyes and intravenously injected to heirless mice. Two hours after treatment mice were euthanized, organs were excised, fluorescence was registered by IVIS imaging system and normalized per gram of tissue weight in each organ

Suppression of JNK1 protein {#Sec19}
---------------------------

Suppression of the targeted JNK1 mRNA and protein by ASO or siRNA delivered by liposomes was studied by RT-PCR and immunohistochemical protein staining. The results showed that hypoxia led to the significant overexpression of the JNK1 gene and protein (Fig. [5a](#Fig5){ref-type="fig"} (bar 2), b for the gene and protein, respectively). Empty neutral or cationic liposomes did not have a significant influence on this overexpression (Fig. [5a](#Fig5){ref-type="fig"} (bars 3 and 4), b). Treatment of mice with liposomes containing ASO or siRNA targeted to JNK1 mRNA led to a substantial decrease in the expression of this gene and protein in the lungs and heart under hypoxic conditions (Fig. [5a](#Fig5){ref-type="fig"} (bars 5 and 6), b). In contrast, treatment of mice with liposomes contained JNK1 ASO or siRNA did not influence the expression of either the mRNA or protein in the brain under hypoxic exposure. In general, one can conclude that the efficiency of the suppression of targeted JNK1 mRNA and protein correlated with the organ content of delivered ASO or siRNA. Fig. 5Expression of JNK1 gene and protein in mouse organs under normoxia and hypoxia. Hypoxia was induced in mice by the inhalation of gas mixture containing 6% O~2~ for 2 h. Control mice (normoxia, *1*) breathed room air (21% O~2~) in the same chamber as animals with hypoxia. Mice were treated with saline (normoxia -- control, *1*; hypoxia, *2*) and indicated substances (*3*--*6*) immediately before the exposure. **a** Typical gel electrophoresis images of RT-PCR products and average expression of the *JNK1* gene. Gene expression was calculated as a ratio of band intensity of *JNK1* gene to that of internal standard (*b-actin)*. Means ± SD are shown. \**P* \< 0.05 when compared with control. **b** Typical images of tissue sections stained with antibody against JNK1 protein. *Dark color* indicates high protein expression

Inhibition of hypoxic cell damage and death {#Sec20}
-------------------------------------------

To examine the hypoxic cellular damage and influence of the suppression of JNK1 on this process, we carried out a histopathological analysis (hematoxylin-eosin stain) and studied the expression of the main cell death signaling protein---caspase 9 and apoptosis induction in the selected tissues. The data show that hypoxia led to the overexpression of both procaspase and active caspase 9 (compare Fig. [6a](#Fig6){ref-type="fig"} (lanes 1 and 2) and b (bars 1 and 2)) in all studied organs. Empty liposomes (neutral and cationic) did not lead to substantial changes in the expression of procaspase and active caspase 9 (Fig. [6a](#Fig6){ref-type="fig"} (lanes 3 and 4), b (bars 3 and 4)). Systemic delivery of ASO and siRNA prior to hypoxia limited the activation of this pathway of apoptosis leading to the decrease in the expression of both procaspase and active caspase 9 in the lungs and heart (Fig. [6a](#Fig6){ref-type="fig"} (lanes 5 and 6), b (bars 5 and 6)). In contrast, treatment of mice with liposomal ASO and siRNA did not influence the expression of these proteins in the brain under hypoxia. The direct measurements of apoptosis induction in the tissues showed that hypoxia induced cell death in all studied organs (Fig. [7](#Fig7){ref-type="fig"}). In fact, enrichment of histone-associated DNA fragments (mono- and oligo-nucleosomes) in homogenates of the lungs was increased 22--27 times in the lungs and 12--15 times in the heart and brain (compare bars 1 and 2, hypoxia, in Fig. [7](#Fig7){ref-type="fig"}). Similar to the expression of pro-apoptotic caspase 9 protein, empty liposomes did not influence significantly on the level of apoptosis in all organs in normoxia and hypoxia (Fig. [7](#Fig7){ref-type="fig"} (bars 2 and 3)). In contrast, ASO or siRNA delivered by liposomes into the cells after their systemic administration significantly limited hypoxic activation of cell death in the lungs and brain (Fig. [7](#Fig7){ref-type="fig"} (bars 4 and 5, hypoxia)). Fig. 6Expression of caspase 9 in mouse organs under normoxia and hypoxia. Hypoxia was induced in mice by the inhalation of gas mixture containing 6% O~2~ for 2 h. Control mice (normoxia, *1*) breathed room air (21% O~2~) in the same chamber as animals with hypoxia. Mice were treated with saline (normoxia -- control, *1*; hypoxia, *2*) and indicated substances (*3*--*6*) immediately before the exposure. **a** Representative images of Western blots of procaspase and active caspase 9 and β-actin (internal standard) proteins and **b** densitometric analysis of bands. Band intensities of pro- and active caspase 9 are expressed as the percentage of the β*-*actin band intensity, which was set at 100%. Means ± SD are shown. \**P* \< 0.05 when compared with controlFig. 7Apoptosis intensity in different organs of mice during normoxia and hypoxia. Hypoxia was induced in mice by the inhalation of gas mixture containing 6% O~2~ for 2 h. Control mice (normoxia) breathed room air (21% O~2~) in the same chamber as animals with hypoxia. Mice were treated with indicated substances immediately before the exposure. Means ± SD are shown. \**P* \< 0.05 when compared with normoxia. **+***P* \< 0.05 when compared with hypoxic mice treated with saline

As an example of tissue histological changes, lung tissues of mice exposed to 6% oxygen for 2 h were used. Hematoxylin-eosin stain of lung tissue under normoxia and hypoxia showed that hypoxia led to the serious lung injury. In addition to apoptosis, hypoxia caused necrotic cell death. As shown in the bottom panel of Fig. [8](#Fig8){ref-type="fig"}, lung tissue edema is observed under hypoxia (no treatment). In mice treated with liposomal ASO and siRNA targeted to JNK1 mRNA, necrotic damage and edema produced by hypoxia were significantly less pronounced. In correlation with the organ distribution of liposomal ASO and siRNA, treatment of mice breathing hypoxic gas mixture with liposomes containing ASO or complexated with siRNA did not influence the hypoxic tissue and cellular damage in the brain (Figs. [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"}, and [7](#Fig7){ref-type="fig"}). Fig. 8Typical light microscopy images of lung tissue sections stained with hematoxylin-eosin. Hypoxia was induced in mice by the inhalation of gas mixture containing 6% O~2~ for 2 h. Control mice (normoxia) breathed room air (21% O~2~) in the same chamber as animals with hypoxia. Mice were treated with saline and indicated substances immediately before the exposure

Discussion {#Sec21}
==========

Based on the analysis of literature data (Bennett et al. [@CR1]; Zhou et al. [@CR64]) and our previously reported in vitro results (Betigeri et al. [@CR2]), we hypothesized that suppression of JNK1 protein will limit cell death and tissue damage induced by severe hypoxia. To verify our hypothesis, we carried out experiments on mice exposed to exogenous hypoxia caused by inhalation of gas mixture containing 6% oxygen. In order to suppress JNK1 protein, we used neutral liposomes containing P-ethoxy-modified electrically neutral ASO and cationic liposomes complexed with siRNA. ASO and siRNA were designed to suppress JNK protein expression. The liposomes containing active payload were intravenously injected into the tail vein of the mice before hypoxic exposure. Control mice received saline or empty liposomes of both types. As expected, breathing a gas mixture containing 6% O~2~ within 2 h induced severe hypoxia associated with lactic acid accumulation in all studied organs. This tissue hypoxia induced caspase-dependent cell death signaling pathway and led to substantial apoptosis induction and tissue damage. After systemic administration, ASO or siRNA delivered by liposomes accumulated in all studied organs excluding the brain. This led to the suppression of targeted JNK1 protein, break down of the cell death signal, limited apoptosis, necrosis and tissue damage under hypoxic exposure. The observed suppression of cell death was evident only in organs with substantial accumulation of liposomal ASO or siRNA, which confirmed that the inhibition of targeted protein following hypoxic cellular damage was caused by ASO or siRNA targeted to JNK1 mRNA delivered by liposomes. Consequently, the defensive action of the treatment was associated with the direct local suppression of targeted JNK1 protein but not with other systemic effects. Therefore, we were able to verify the hypothesis and provide proof of concept of a unique approach to the prevention of cellular damage under severe hypoxia by the suppression of JNK1 hypoxic pathways.

Other approaches can be potentially used separately or in combination with the suppression of JNK1 to limit or prevent tissue damage during hypoxia (Minko et al. [@CR40]). Previously we have shown that antioxidant α-tocopherol delivered by liposomes significantly limited hypoxic damage under lung edema (Minko et al. [@CR39]). Liposomal antioxidant agents were also successfully used to protect organs from ischemic damage (Rivera et al. [@CR52]; Sinha et al. [@CR53]). In addition, gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide was tested (Ko et al. [@CR31]). Therefore, the combination of gene and antioxidant therapy has high potential in treatment of hypoxic tissue damage.

The experimental data clearly showed the correlation between the accumulation of delivered ASO or siRNA in organs and anti-hypoxic effect of the treatment. In fact, relatively high accumulation of liposomes and their payload in the lungs and heart substantially limited cell death induction in these organs. In contrast, a trace amount of liposomes, ASO and siRNA accumulated in the brain after systemic administration and was not able to prevent hypoxic brain tissue damage. Therefore, a different strategy and thus a special approach to the delivery through the blood--brain barrier should be used in order to prevent the damage to the brain during severe hypoxia. Conjugation of liposomes with TAT peptide (Gupta et al. [@CR22]; MacKay et al. [@CR34]; Rapoport and Lorberboum-Galski [@CR50]) or transferrin (Soni et al. [@CR55]) potentially can be used in order to accomplish the penetration of liposomes via the blood--brain barrier and delivery of drugs and other active components to the brain.
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